Tepnel Life Sciences Receives GBP92.8 Million Offer From Gen-Probe
January 30 2009 - 3:22AM
Dow Jones News
Diagnostics company Tepnel Life Sciences PLC (TED.LN) said
Friday it agreed a GBP92.8 million takeover by U.S. peer Gen-Probe
Inc. (GPRO).
Gen-Probe is offering Tepnel shareholders 27.1 pence in cash per
share, more than double Tepnel's share price on Jan. 21, when it
said it received an approach.
The acquisition of Tepnel will allow Gen-Probe to expand into
tests for monitoring transplant recipients, the firm said.
Company Web site: www.tepnel.com
-By Jason Douglas, Dow Jones Newswires; 44-20-7842-9272;
jason.douglas@dowjones.com
Click here to go to Dow Jones NewsPlus, a web front
page of today's most important business and market news, analysis
and commentary. You can use this link on the day this article is
published and the following day.
Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024
Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024